#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma refractory Friedreich's ataxia Idiopathic pulmonary fibrosis Primitive neuroectodermal tumour Bladder cancer Hodgkin's disease refractory Glomerulonephritis acute Synovial sarcoma metastatic Hypergammaglobulinaemia benign monoclonal Intracranial germ cell tumour Paget's disease of the vulva Infective uveitis Insulinoma Oesophageal carcinoma Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Trials in Disease Mast cell activation syndrome – Basic Information Rosai-Dorfman syndrome – Trials in Disease Pulmonary fibrosis – Diagnostics Hereditary optic atrophy Mantle cell lymphoma stage IV – Basic Information Brain stem glioma – Trials in Disease Chondrosarcoma metastatic – Life with Disease Methylmalonic acidaemia – Trials in Disease Angiosarcoma non-metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pitolisant AGALSIDASE BETA Escitalopram Blu-222 ZIRCONIUM (89ZR) GIRENTUXIMAB Naproxen Sodium Alogliptin Fluticasone Furoate Anhydrous Glucose Bp Oxacillin Adrc001 Phleum Pratense Cedazuridine Anhydrous Benzoyl Peroxide Tinzaparin Sodium Cytisine Cetrimide Prilocaine INSULIN DEGLUDEC H2-Receptor Antagonist More therapies…

    Learn about Your Condition

    Fallopian tube cancer Malignant lymphoid neoplasm Marginal zone lymphoma Lymphocyte adoptive therapy Periodontitis Leukaemia Acute HIV infection Psychotic disorder Vulvovaginal dryness Migraine Nocturia Ependymoma Uterine leiomyosarcoma Respiratory failure Von Willebrand's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ischaemic stroke

  • A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Bulgaria Greece Hungary Norway Romania Spain

  • A Study of Tenecteplase for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Germany

  • A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

    Recruiting

    4 1
    Belgium France Hungary Poland Romania Spain

  • A Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness

    Recruiting

    1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • UROKINASE, CATALYTIC DOMAIN, FUSED WITH A SINGLE-CHAIN ANTIBODY AGAINST VON WILLEBRAND FACTOR
    • Sodium Chloride Solution 0.9%
    Germany Poland Spain

  • A study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Germany

  • Study of cangrelor and acetylsalicylic acid in patients with ischemic stroke requiring emergency carotid artery stenting and mechanical thrombectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    Austria
1 2 3 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!